Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:17:07.331Z.
Calculation as of: 2026-10-06T19:17:07.331Z.
Quote observation: 2026-10-06T19:15:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d6f46135b6530101ad9b4588db83b8c95ba7a1cad5aa1084b13b7f0580fbae0b
EARNINGS YIELD
N/A
Market Cap
$3.50B
Earnings Yield
N/A
TTM Avg
3.23%
3Y Avg
3.30%
5Y Avg
3.30%
Market Cap
$3.39B
Earnings Yield
11.23%
TTM Avg
8.17%
3Y Avg
6.43%
5Y Avg
6.43%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | $3.46B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | N/A | N/A | N/A | N/A |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.50B | N/A | 3.23% | 3.30% | 3.30% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 11.23% | 8.17% | 6.43% | 6.43% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.54B | N/A | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.54B | 3.16% | 1.91% | 1.65% | 1.65% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | N/A | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.33B | 3.22% | 5.71% | 6.07% | 6.07% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
